The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cellsLucia Mazzacurati, Gary W. Reuther|Oncotarget|2015Cited by 38